0001213900-22-028974.txt : 20220523
0001213900-22-028974.hdr.sgml : 20220523
20220523163051
ACCESSION NUMBER: 0001213900-22-028974
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220519
FILED AS OF DATE: 20220523
DATE AS OF CHANGE: 20220523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DeLuca Teresa
CENTRAL INDEX KEY: 0001685627
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38105
FILM NUMBER: 22952125
MAIL ADDRESS:
STREET 1: 40 BURTON HILLS BOULEVARD, SUITE 500
CITY: NASHVILLE
STATE: TN
ZIP: 37215
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 180 Life Sciences Corp.
CENTRAL INDEX KEY: 0001690080
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813832378
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 830 MENLO AVENUE, SUITE 100
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-507-0669
MAIL ADDRESS:
STREET 1: 830 MENLO AVENUE, SUITE 100
CITY: MENLO PARK
STATE: CA
ZIP: 94025
FORMER COMPANY:
FORMER CONFORMED NAME: KBL MERGER CORP. IV
DATE OF NAME CHANGE: 20161115
4
1
ownership.xml
X0306
4
2022-05-19
0
0001690080
180 Life Sciences Corp.
ATNF
0001685627
DeLuca Teresa
3000 EL CAMINO REAL
BLDG. 4, SUITE 200
PALO ALTO
CA
94306
1
0
0
0
Common Stock
5000
D
Common Stock
2500
I
By Trust
Common Stock
2500
I
By Trust
Common Stock
2500
I
By Spouse
Non-Qualified Stock Option (right to buy)
1.36
2022-05-19
4
A
0
21000
0.0
A
2032-05-19
Common Stock
21000
21000
D
Shares are held by The Santina Iraggi Irrvoc TR, U/A 11/2/20, an irrevocable trust, of which the Reporting Person is beneficiary and trustee.
Shares are held by the REV TR FBO Teresa M Deluca, a revocable trust, of which the Reporting Person is beneficiary and trustee.
Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt pursuant to Rule 16b-3.
The Options vest at the rate of 1/39th of such options ratably on a monthly basis over the 39 months following the grant date, on the last day of each calendar month (beginning on May 31, 2022), subject to the holder's continued service to the Company.
/s/ Teresa DeLuca
2022-05-23